These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12058792)

  • 21. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of serum total cholesterol and other risk factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention Study.
    Iwashita M; Matsushita Y; Sasaki J; Arakawa K; Kono S;
    Circ J; 2004 May; 68(5):405-9. PubMed ID: 15118279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
    von Eckardstein A; Schulte H; Cullen P; Assmann G
    J Am Coll Cardiol; 2001 Feb; 37(2):434-9. PubMed ID: 11216959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
    Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm.
    Miwa K; Nakagawa K; Yoshida N; Taguchi Y; Inoue H
    J Am Coll Cardiol; 2000 Apr; 35(5):1200-5. PubMed ID: 10758961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women.
    Nguyen TT; Ellefson RD; Hodge DO; Bailey KR; Kottke TE; Abu-Lebdeh HS
    Circulation; 1997 Sep; 96(5):1390-7. PubMed ID: 9315522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
    Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
    Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of Lipoprotein (a) for Predicting Outcomes After Percutaneous Coronary Intervention for Stable Angina Pectoris in Patients on Hemodialysis.
    Hishikari K; Hikita H; Yoshikawa H; Abe F; Tsujihata S; Ito N; Kanno Y; IIya M; Murai T; Takahashi A; Yonetsu T; Sasano T
    Am J Cardiol; 2020 Dec; 136():32-37. PubMed ID: 32941820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
    Horiuchi H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
    J Am Geriatr Soc; 2004 Dec; 52(12):1981-7. PubMed ID: 15571531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
    Rosengren A; Wilhelmsen L; Eriksson E; Risberg B; Wedel H
    BMJ; 1990 Dec; 301(6763):1248-51. PubMed ID: 2148699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients.
    Cohen HW; Hailpern SM; Alderman MH
    Hypertension; 2004 May; 43(5):983-7. PubMed ID: 15037563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study).
    Deen JF; Rhoades DA; Noonan C; Best LG; Okin PM; Devereux RB; Umans JG
    Am J Cardiol; 2017 Jun; 119(11):1757-1762. PubMed ID: 28416200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.
    Willett WC; Green A; Stampfer MJ; Speizer FE; Colditz GA; Rosner B; Monson RR; Stason W; Hennekens CH
    N Engl J Med; 1987 Nov; 317(21):1303-9. PubMed ID: 3683458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.
    Cantin B; Gagnon F; Moorjani S; Després JP; Lamarche B; Lupien PJ; Dagenais GR
    J Am Coll Cardiol; 1998 Mar; 31(3):519-25. PubMed ID: 9502629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease].
    Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA; Pokrovskiĭ SN
    Kardiologiia; 2002; 42(5):4-8. PubMed ID: 12494139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists.
    Yamagishi M; Ito K; Tsutsui H; Miyazaki S; Goto Y; Nagaya N; Sumiyoshi T; Fukami K; Haze K; Kitakaze M; Nonogi H; Tomoike H
    Circ J; 2003 Dec; 67(12):1029-35. PubMed ID: 14639019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden.
    Glader CA; Birgander LS; Stenlund H; Dahlén GH
    J Intern Med; 2002 Jul; 252(1):27-35. PubMed ID: 12074735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
    Packard CJ; O'Reilly DS; Caslake MJ; McMahon AD; Ford I; Cooney J; Macphee CH; Suckling KE; Krishna M; Wilkinson FE; Rumley A; Lowe GD
    N Engl J Med; 2000 Oct; 343(16):1148-55. PubMed ID: 11036120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.